Paper4953364
Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome).
Aberfeld DC and 2 others. Brain, 1965. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome). Papers, record 4953364. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4953364
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome).
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Diseases | Major topic |
| Dwarfism | Major topic |
| Eye Abnormalities | Major topic |
| Facial Expression | Major topic |
| Myotonia | Major topic |
| Child | |
| Diagnosis, Differential | |
| Female | |
| Humans | |
| Male | |
| Mucopolysaccharidosis IV |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38212959 | Schwartz-Jampel Syndrome Type 1: Compound Heterozygosity of Two Novel Variants | J Clin Res Pediatr Endocrinol | 2026 | https://conductscience.org/library/papers/38212959 | PubMed |
| 29386878 | Insight into the molecular genetics of myopia. | Mol Vis | 2017 | https://conductscience.org/library/papers/29386878 | PubMed |
| 18629873 | Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators. | Dev Dyn | 2008 | https://conductscience.org/library/papers/18629873 | PubMed |
| 16466400 | Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts. | Differentiation | 2006 | https://conductscience.org/library/papers/16466400 | PubMed |
| 15758379 | Perlecan: an important component of the cartilage pericellular matrix. | J Musculoskelet Neuronal Interact | 2002 | https://conductscience.org/library/papers/15758379 | PubMed |
| 11941538 | Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. | Am J Hum Genet | 2002 | https://conductscience.org/library/papers/11941538 | PubMed |
| 9279765 | Genetic heterogeneity in Schwartz-Jampel syndrome: two families with neonatal Schwartz-Jampel syndrome do not map to human chromosome 1p34-p36.1. | J Med Genet | 1997 | https://conductscience.org/library/papers/9279765 | PubMed |
| 6716408 | Late infantile autosomal recessive myotonia, mental retardation, and skeletal abnormalities: a new autosomal recessive syndrome. | J Med Genet | 1984 | https://conductscience.org/library/papers/6716408 | PubMed |
| 3873520 | Schwartz-Jampel syndrome associated with von Willebrand's disease. | J Neurol | 1985 | https://conductscience.org/library/papers/3873520 | PubMed |
| 632822 | Schwartz-Jampel syndrome in two daughters of first cousins. | J Neurol Neurosurg Psychiatry | 1978 | https://conductscience.org/library/papers/632822 | PubMed |
| 173806 | Early onset myotonic dystrophy in association with polyneuropathy. | J Neurol Neurosurg Psychiatry | 1975 | https://conductscience.org/library/papers/173806 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4953364
GET https://conductscience.org/api/papers/v1/4953364/authors